Tag Archives: business

Chinese In-Licensing Continues to Strengthen

Chinese companies are eager to collaborate with their ex-China counterparts, and in-licensing agreements are outpacing other forms of biotech deal-making in 2013. In fact, the number of in-licensing deals announced so far this year is more than the combined number of 2012 deals in out-licensing, JV/Alliance and M&A, according to BIO’s Industry Analysis research and GBI. This deal-making momentum bodes well for small and medium-sized biotech companies that have early-stage compounds under development in the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Build Credibility As You Build Your Business

Dan Eramian

Whether you are a first-time entrepreneur or a veteran company executive, the one aspect of growing a business and raising capital, or selling a product rarely discussed at seminars is the building of your organization’s credibility. It doesn’t get much attention when you issue your quarterly report because it is not always easy to measure that quality directly in dollars and cents. Busy CEOs and company executives charged with concentrating on bottom line finances and product advancement Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

New Year, New Resolutions: Kickstart Your Career with the BIO International Convention

BIO International Convention

With 2012 behind us and 2013 well under way, now is the time to re-establish professional goals for a prosperous year. BIO’s events serve as a professional networker’s playground and our flagship event, the BIO International Convention is a little more than 100 days away. If your 2013 to-do list includes professional enrichment and business development, the BIO International Convention is the place to be in April. Here a few tips to help kick start Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

BioManufacturers Increasing Budgets for New Technologies

Eric Langer

By Eric Langer, Managing Partner, BioPlan Associates, Inc. Two-thirds Spending more for Improved Productivity Almost two-thirds (64.2 percent) of biomanufacturers will increase their budgets for new technologies to improve efficiencies and costs for downstream production this year. Data from our newly released 9th Annual Report and Survey of Biopharmaceutical Manufacturers, include responses from 302 global biomanufacturers, and an additional 185 vendors to the industry. We find that budget increases this year are not just incremental Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

IPO Update – Jan 2012

IPO-raised-vs-filed-2009-20112

2011 ended quietly for the US biotech IPO market. It has now been almost two months without a biotech IPO. The last few IPOs back in November continued the theme that was in place at the beginning of the year – you can get out, but with a -30% haircut. In fact, only two of the 12 IPOs in 2011 raised more than they filed for. This is shown in chart 1 below. The two Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , ,